alexion-pharmaceuticals

Alexion Pharmaceuticals was a global biopharmaceutical company headquartered in Boston, Massachusetts, focused on developing life-transforming therapies for rare diseases. Founded in 1992, the company pioneered complement inhibition therapy and developed leading treatments for rare hematological and neurological conditions including Soliris (eculizumab) and Ultomiris (ravulizumab). AstraZeneca acquired Alexion in July 2021 for $39 billion, and the company now operates as Alexion, AstraZeneca Rare Disease. The combined entity maintains research programs in complement biology, hematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. Alexion's GitHub organization (alxndgb) hosts research tools including genomic data analysis platforms, precision medicine knowledge graphs, and rare disease target discovery systems.

alexion-pharmaceuticals is profiled on the APIs.io network. Tagged areas include Pharmaceuticals, Rare Disease, Biopharmaceutical, Healthcare, and Genomics.

alexion-pharmaceuticals’ developer surface includes GitHub presence and 5 more developer resources.

🌐 Visit website 📡 Source on GitHub

7.6/100 minimal ▬ flat Agent 4/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

PharmaceuticalsRare DiseaseBiopharmaceuticalHealthcareGenomicsComplement BiologyHematologyNeurology

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 7.6/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.0 / 20

Commercial Clarity 0.0 / 20

Operational Transparency 0.7 / 13

Governance 0.0 / 12

Discoverability 6.0 / 10

Agent readiness — 4/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 4 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/alexion-pharmaceuticals: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Agent Surfaces 2

MCP servers, agent skills, and machine-readable catalogs

WellKnown

WellKnown

LLMsTxt

LLMsTxt

Build 1

SDKs, sample code, and the tooling you integrate with

GitHub

GitHub

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Company 2

The organization behind the API

Website

Website

Website

Website

Source (apis.yml)

aid: alexion-pharmaceuticals
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/alexion-pharmaceuticals.png
url: https://raw.githubusercontent.com/api-evangelist/alexion-pharmaceuticals/refs/heads/main/apis.yml
modified: '2026-06-20'
description: Alexion Pharmaceuticals was a global biopharmaceutical company headquartered in Boston, Massachusetts, focused
  on developing life-transforming therapies for rare diseases. Founded in 1992, the company pioneered complement inhibition
  therapy and developed leading treatments for rare hematological and neurological conditions including Soliris (eculizumab)
  and Ultomiris (ravulizumab). AstraZeneca acquired Alexion in July 2021 for $39 billion, and the company now operates as
  Alexion, AstraZeneca Rare Disease. The combined entity maintains research programs in complement biology, hematology, nephrology,
  neurology, metabolic disorders, cardiology, and ophthalmology. Alexion's GitHub organization (alxndgb) hosts research tools
  including genomic data analysis platforms, precision medicine knowledge graphs, and rare disease target discovery systems.
apis: []
common:
- type: DomainSecurity
  url: security/alexion-pharmaceuticals-domain-security.yml
- type: Website
  url: https://alexion.com
- type: Website
  url: https://www.astrazeneca.com/our-therapy-areas/rare-disease.html
- type: GitHub
  url: https://github.com/alxndgb
- type: WellKnown
  url: well-known/alexion-pharmaceuticals-well-known.yml
- type: LLMsTxt
  url: llms/alexion-pharmaceuticals-llms.txt
tags:
- Pharmaceuticals
- Rare Disease
- Biopharmaceutical
- Healthcare
- Genomics
- Complement Biology
- Hematology
- Neurology